LIDOCAINE 5%

Manufacturer
Shield Line LLC | UMENDRA LIFE SCIENCES PRIVATE LIMITED
Effective date
2026-11-03
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
daily-update
Hydrated at
2026-11-06 02:02:44

Label at a glance#

ProductMEDPRIDE RELIEF
Active ingredientLIDOCAINE
Label structure9 sections

Indications and uses

helps relieve the pain, itching, and burning, associated with hemorrhoids and anorectal disorders.

Dosage and administration

Adult and children 12 years and over: when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product. apply externally to the affected area up to 6 times a day children under 12 years of age: consult a doctor.

Storage and handling

Store between 15°-30° C (59°-30° F)

Label contents#

Full prescribing information#

ACTIVE INGREDIENT

OTC - ACTIVE INGREDIENT SECTION

Lidocaine 5% W/W

PURPOSE

OTC - PURPOSE SECTION

Local Anesthetic

USES

INDICATIONS & USAGE SECTION

helps relieve the pain, itching, and burning, associated with hemorrhoids and anorectal disorders.

WARNINGS

WARNINGS SECTION

For external use only

When using this product

OTC - WHEN USING SECTION

  • use only as directed
  • avoid contact with eyes
  • do not exceed recommended dosage unless directed by a doctor
  • do not put this product into the rectum by using fingers or any mechanical device or applicator

Stop use and ask a doctor if

OTC - STOP USE SECTION

  • rectal bleeding occurs
  • condition worsens or does not improve within 7 days
  • symptoms clear up and occur again within a few days
  • an allergic reaction develops to ingredients in this product
  • symptom being treated does not subside or if redness, irritation, swelling, pain or other symptoms develop or increase

If pregnant or breast-feeding,

OTC - PREGNANCY OR BREAST FEEDING SECTION

ask a health professional before use.

Keep out of reach of children and pets.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

DIRECTIONS

DOSAGE & ADMINISTRATION SECTION

Adult and children 12 years and over:

  • when practical, cleanse the affected area with mild soap and warm water and rinse thoroughly. Gently dry by patting or blotting with toilet tissue or a soft cloth before application of this product.
  • apply externally to the affected area up to 6 times a day

children under 12 years of age: consult a doctor.

OTHER INFORMATION

STORAGE AND HANDLING SECTION

Store between 15°-30° C (59°-30° F)

INACTIVE INGREDIENTS

INACTIVE INGREDIENT SECTION

Benzyl Alcohol, Carbomer 940, Cholesterol, Isopropyl Myristate, Lecithin (Soya), Polysorbate 80, Propylene Glycol, Purified Water, Triethanolamine, Vitamin-E Acetate

QUESTIONS

OTC - QUESTIONS SECTION

1-888-277-6533

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Drug Fact PanelDrug Fact PanelPrincipal Display

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 13 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
52410-109052410-1090-3

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MEDPRIDE RELIEFLIDOCAINE 5%Shield Line LLC5f644122-dd11-ab7f-e063-6394a90a080a2026-11-03WarningsExact identifier
ndc (package): 52410-1090-3
ndc (product): 52410-1090
ndc11 (package): 52410109003
spl id: 5f64412f-2c05-22ab-e063-6294a90a93a3
spl set id: 5f644122-dd11-ab7f-e063-6394a90a080a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.